Ethinylestradiol, five white each containing levonorgestrel, six light brown each containing levonorgestrel, ten yellow each containing levonorgestrel
Sold as Trigestrel
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Trigestrel EACH PACK CONTAINS: Six light brown tablets each containing: LEVONORGESTREL 50,0 μg ETHINYLESTRADIOL 30,0 μg Five white tablets each containing: LEVONORGESTREL 75,0 μg ETHINYLESTRADIOL 40,0 μg Ten yellow tablets each containing: LEVONORGESTREL 125,0 μg ETHINYLESTRADIOL 30,0 μg Seven inert tablets | 0,05 mg/0,03 mg; 0,075 mg/0,04 mg; 0,125 mg/0,03 mgTablets. | A400743A40/18.8/0743Approved 16 November 2022 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.